StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Cowen Reiterates Outperform Rating on Outset Medical Inc. (OM), Comments on FDA Clearance
August 1, 2022 8:58 AM
Cowen analyst Joshua Jennings reiterated an Outperform rating and $33.00 price target on Outset Medical Inc. (NASDAQ: OM).The analyst comments ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Hot Comments
Next Articles
Outset Medical Inc. (OM) to Resume Trading at 10:30 a.m.
August 1, 2022 10:15 AM
Outset Medical Inc. (OM) Misses Q2 EPS by 13c
August 1, 2022 10:04 AM
Outset Medical (OM) Resumes Shipment of Tablo Systems for Home Use, Reports Second Quarter 2022 Financial Results and Provides 2022 Guidance
August 1, 2022 10:03 AM
Outset Medical Inc. (OM) Halted, News Pending
August 1, 2022 9:37 AM
Stifel on Outset Medical Inc. (OM): 'At Last, A Big Sigh of Relief As FDA Terms Tablo Catch-Up Filing As “Substantially-Equivalent”'
August 1, 2022 8:57 AM
Outset Medical Inc. (OM) Gains 6% Premarket; Cowen Cites FDA Clearance - Bloomberg
August 1, 2022 8:55 AM
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Wells Fargo, Unity, Amazon, and Outset Medical and Encourages Investors to Contact the Firm
July 31, 2022 9:00 PM
